DHR Stock Analysis: Buy, Sell, or Hold?
DHR - Danaher Corporation
$198.63
3.65 (1.87%)
▲
5d:
+1.08%
30d:
+0.35%
90d:
+13.41%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 20, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.2/10
Get Alerted When DHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DHR shows positive signals but monitor for confirmation. Market pricing in 2.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: DHR shows positive signals but monitor for confirmation. Market pricing in 2.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$286.81
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$178.09
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DHR is currently trading at $198.63, which is considered fair relative to its 30-day fair value range of $189.37 to $201.08. The stock's valuation (Forward PE: 21.0) is in line with its historical norms (22.5). Remarkably, the market is currently pricing in an annual earnings decline of 2.2% over the next few years. This pessimistic expectation contrasts with the company's recent 59.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DHR is in a strong uptrend. Immediate support is located at $165.75, while resistance sits at $209.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $227.96 (+16.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DHR is in a strong uptrend. Immediate support is located at $165.75, while resistance sits at $209.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $227.96 (+16.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$189.37 -
$201.08
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($227.96)
Trading Range Analysis
30-Day Trading Range
$189.37 -
$201.08
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$165.75
Resistance Level
$209.90
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.99
Wall Street Target
$227.96
(+16.9%)
Revenue Growth (YoY)
5.5%
Earnings Growth (YoY)
59.7%
Profit Margin
16.0%
Valuation Discount vs History
-2.2% cheaper
PE vs Historical
21.0 vs 22.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.2%
(market-implied from PE analysis)
1-Year Target
$190.69
(-2%)
2-Year Target
$186.50
(-4%)
3-Year Target
$182.39
(-7%)
3-Yr Target (if PE normalizes)
(PE: 21→23)
$195.51
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.0, Growth: 9.1%)
$253.51
(+30%)
Base:
(SPY PE: 20.7, Growth: 9.1%)
$250.36
(+28%)
Bear:
(PE: 17.6, Growth: 9.1%)
$212.80
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 34.97 | Current EPS (TTM): $5.61
Bull Case
$357.29
(+83%)
Analyst growth 65.6%, PE expands to 38.5
Base Case
$324.81
(+67%)
Market implied 65.6%, PE stable at 35.0
Bear Case
$133.40
(-32%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.0 to 22.5
Stabilization Target:
$209.00
(+7.2%)
PE Expansion Potential:
+7.2%
Share & Embed Analysis
Last updated: August 03, 2026 2:01 PM ET
Data refreshes hourly during market hours. Next update: 3:01 PM
Data refreshes hourly during market hours. Next update: 3:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DHR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Ro Khanna
SELL
2026-02-24
Featured in Portfolios
DHR is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$273 | 64 BUY |
Advanced DHR Option Strategies
Professional options setups generated by AI based on today's DHR price and gamma walls.
